Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 331 Projects
Project # Contact PI Funding Organization Fiscal Year
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Sninsky, John Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Wilson, David Alzheimer's Drug Discovery Foundation 2022
Discovery of selective LRP1 inhibitors to prevent tau uptake and spread
ADDF-57 Kosik, Kenneth Alzheimer's Drug Discovery Foundation 2022
Repairing neurotransmission in Alzheimer's disease and related disorders by targeting caspase-2
ADDF-58 Ashe, Karen Alzheimer's Drug Discovery Foundation 2022
FINGERS Brain Health Institute
ADDF-59 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2022
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Menniti, Frank Alzheimer's Drug Discovery Foundation 2021
Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)
ADDF-33 Edison, Paul Alzheimer's Drug Discovery Foundation 2021
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Plasma pathologic TDP-43 as a biomarker for FTLD-TDP
ADDF-36 Mao, Qinwen Alzheimer's Drug Discovery Foundation 2021